|Articles|February 25, 2009
Managing submacular haemorrhage in CNV membrane
Pneumatic displacement and intravitreal bevacizumab: A new approach for management of submacular hemorrhage in choroidal neovascular membrane
Advertisement
Please click
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Long-term follow-up in paediatric gene therapy
2
Macular laser picks up speed: The technology accelerating retinal therapies
3
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
4
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
5








































